Sanofi gains OTC rights to Roche’s Tamiflu in US
Tuesday, July 23, 2019 Sanofi has entered an agreement to obtain the exclusive over-the-counter (OTC) rights for Roche’s Tamiflu medicine.
Read More
Tuesday, July 23, 2019 Sanofi has entered an agreement to obtain the exclusive over-the-counter (OTC) rights for Roche’s Tamiflu medicine.
Read MoreTuesday, July 23, 2019 DrugName : NanoVax (HSV) vaccine herpes simplex virus 2 vaccine BlueWillow Biologics announced the issuance of U.S.
Read MoreThe term of validity of mailbox drug patents in Brazil is limited to twenty years from the filing date of
Read MoreThursday, May 30, 2019 This research work reviews the pros and cons of the existing cell-laden rapid prototyping (RP)
Read MoreMonday, July 22, 2019 Gilead Sciences has secured an antiviral deal with Novartis to gain exclusive global rights to preclinical
Read More